Brandli v. Micrus Endovascular Corporation

209 F. Supp. 3d 356, 2016 U.S. Dist. LEXIS 128581, 2016 WL 5239841
District Court, District of Columbia·Decided September 21, 2016·No. Civil Action No. 2011-1743·Published·Cited by 6 cases

Opinion

OPINION

PAUL L. FRIEDMAN, United States District Judge

Plaintiff Karen Brandli brought this sex discrimination suit against her former employer, Micrus Endovascular Corporation (“Micrus”), Johnson & Johnson Services, Inc. (“JJSI”), Codman & Shurtleff, Inc. (“Codman”), and James Bertrand. Brandli was a Micrus employee under Bertrand’s supervision until 2010 when JJSI acquired Micrus and merged it with Codman, a business JJSI owned. In the process, Mi-crus terminated Brandli’s employment. Defendants have collectively moved for summary judgment on the grounds that they had legitimate, nondiscriminatory reasons for not retaining Brandli and that Brandli failed to produce evidence that these reasons are a pretext for discrimination on the basis of sex. The Court heard oral argument on this motion on June 15, 2016. Upon careful consideration of the parties’ written and oral arguments, the entire record in this case, and the relevant statutes and case law, the Court will grant defendants’ motion. 1

*358 I. BACKGROUND

Karen Brandli began working for Mi-crus as an account manager in 2006, selling neurosurgery devices in Washington, D.C., Northern Virginia, Maryland, and West Virginia. Am. Compl. ¶ 25; Defs. SMF ¶¶ 1-3. Brandli’s sales quota for Micrus’s fiscal year 2007 was $995,000, a quota she substantially exceeded by selling approximately $2.4 million dollars worth of Mieras products during that period. Am. Compl. ¶ 82. As a result, Mieras nominated her for its “Sales Rep of the Year” and “Rookie of the Year” awards. Id. ¶ 33. In April 2007, Mieras removed Virginia and West Virginia from Brandli’s territory and gave them to a new sales representative, Steve Tripp. Id. ¶ 36. In 2007, Mieras released the director of sales who had hired Brandli and replaced him with James Bertrand. Id. ¶ 37.

Mieras reassigned Brandli in 2008 from the northeast region sales territory to the southeast region sales territory. Defs. SMF ¶ 4. At that time, Brandli complained to her regional manager that she believed Bertrand was attempting to force her out of her sales territory. Am. Compl. ¶ 39. The regional manager mentioned to Brandli that Bertrand had been “throwing around” the notion of assigning Brandli to the sales training division, an assignment that would have deprived Brandli of the opportunity to earn commissions. Id. ¶¶ 38-40. Brandli alleges that during a conference call in 2008 Bertrand stated that he was going to “get rid of’ her, and that another manager advised Bertrand not to “do anything more with women right now, because we may have an issue.” Id. ¶¶ 55-56. Bertrand denies making both statements, and two managers who were present for the conference call confirmed in deposition testimony that Bertrand did not say that he was going to “get rid of’ Brandli. Defs. SMF ¶ 32.

In 2009, Brandli acquired a new account, Chistiana Hospital, and earned for Mieras the majority of Chistiana Hospital’s medical coil device business. Am. Compl. ¶ 59. As a result, Mieras awarded her “President’s Club” status and ranked her as the number three sales representative in North America. Id. ¶ 60; see also Opp. Ex. 22 [Dkt. 33-32]. Bertrand’s predecessor conducted a field visit with Brandli in 2009 and wrote an “excellent review and praised her sales efforts, product knowledge, and relationship with clients.” Opp. at 4; see also Opp. Ex. 21 [Dkt. 33-31]. Her strong performance continued in 2010 when she reached 96% of her yearly quota by April. Am. Compl. ¶ 61. But in 2009 Brandli received a rating of “meets expectation” as opposed to the higher rating of “exceeds expectation,” and defendants assert that Brandli’s supervisor received customer complaints that Brandli was “abrasive.” Defs. SMF ¶ 13. Mieras never placed Brandli on a performance improvement plan (“PIP”), a measure that is commonly taken when a sales employee performs below expectations. Opp. at 4.

In 2010, JJSI publicly announced its intention to acquire Mieras. Am. Compl. ¶ 64. JJSI owned Codman, one of Micras’s competitors, and JJSI intended to ran Mi- *359 crus as one of Codman’s business units. Id. ¶ 62; Defs. SMF ¶¶ 5-6. Codman anticipated that there would be overlap in the post-acquisition sales territories, which meant that Codman planned to terminate some sales representatives from the post-acquisition entity. Defs. SMF ¶ 7. On September 29, 2010, Codman informed Brandli that defendants would terminate her employment effective October 31, 2010. Am. Compl. ¶ 71. Defendants thereafter gave sales responsibilities in Brandli’s territory to two male Codman sales representatives, Daniel Garrison and Christopher Kearney. Id. ¶ 96; Defs. SMF ¶ 19.

Brandli filed this sex discrimination suit against the defendants in 2011, alleging that she was terminated on the basis of her sex. Am. Compl. ¶ 2. She initially asserted five claims: (1) against all defendants, a claim of discrimination on the basis of sex in violation of the District of Columbia Human Rights Act (“DCHRA”), D.C. Code § 2—1402.11(a)(1) (2012 Repl.); (2) against Bertrand, a claim of aiding and abetting discrimination on the basis of sex in violation of the DCHRA; (3) against JJSI and Codman, a failure-to-hire claim that is also premised on discriminating on the basis of sex in violation of the DCHRA; (4) against all defendants except Bertrand, a common law negligent hiring claim for the defendants’ hiring of Bertrand; and (5) against Bertrand, a common law tortious interference with business expectations claim. Am. Compl. ¶¶ 100-70. In her opposition to the motion for summary judgment, Brandli stated that she was withdrawing Counts 4 and 5, the common law claims. See Opp. at 1 n.l. In support of her sex discrimination claims, Brandli alleges that defendants: forced her out of her sales territory; forced out other female employees and replaced them with males; required her to prepare reports justifying her sales numbers; placed other female sales representatives on PIPs; failed to select her for a position on the Field Advisory Board; and praised only male employees. Am. Compl. ¶ 105.

Defendants moved for summary judgment on each count of the amended complaint. With respect to the sex discrimination claims, they argue that: (1) they had a legitimate, nondiscriminatory reason for terminating Brandli and that Brandli has not shown that the reason is pretextual; (2) the Court cannot infer discrimination because Garrison and Kearney had stronger credentials than Brandli; (3) Brandli’s failure-to-hire DCHRA claim is not based on a tangible adverse employment action and is untimely; and (4) if the underlying DCHRA claim fails, the aiding-and-abetting claim against Bertrand must also fail. Mot. at 12-26.

II. DISCUSSION

Summary judgment is appropriate only if “the pleadings, depositions, answers to interrogatories, and admissions on file, together with the affidavits, if any, show that there is no genuine issue as to any material fact and that the movant is entitled to judgment as a matter of law.” Anderson v. Liberty Lobby, Inc., 477 U.S. 242, 248, 106 S.Ct. 2505, 91 L.Ed.2d 202 (1986); see Baumann v. District of Columbia, 795 F.3d 209, 215 (D.C.Cir.2015); Fed. R. Civ. P. 56(a), (c).

Free access — add to your briefcase to read the full text and ask questions with AI

Brandli v. Micrus Endovascular Corporation, 209 F. Supp. 3d 356, 2016 U.S. Dist. LEXIS 128581, 2016 WL 5239841 (D.D.C. 2016).

209 F. Supp. 3d 356 (Brandli v. Micrus Endovascular Corporation) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Melkumyan v. Power
District of Columbia, 2024
Grant v. Csl Behring LLC
District of Columbia, 2023
Dickerson v. District of Columbia
District of Columbia, 2022
Baskerville v. CBS News Inc.
District of Columbia, 2022
Breen v. Mineta
253 F. Supp. 3d 244 (District of Columbia, 2017)